Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
US9234034B2 · kind B2 · utility
2Cited by
11References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2012 |
| Grant date | Jan 12, 2016 |
| Priority date | — |
| Expiry date | Dec 21, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.